Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Haematologica|June 13, 2020
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trialOlivier Tournilhac, Magali Le Garff-Tavernier, Stéphanie Nguyen Quoc, et al.
Bone Marrow Transplantation|March 28, 2023
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMTOlivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, et al.
Frontiers in Immunology|April 17, 2024
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sightJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Bone Marrow Transplantation|December 11, 2025
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest linkUgo Chartral, Jeanne Galaine, Camille Giverne, et al.
Bone Marrow Transplantation|January 14, 2018
Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular TherapyJordan Gauthier, Xavier Poiré, Anne-Claire Gac, et al.
Bone Marrow Transplantation|February 11, 2023
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDSClaire Michel, Marie Robin, Stephane Morisset, et al.
American Journal of Hematology|May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Blood Advances|September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Haematologica|April 2, 2026
Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemiaGuillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, et al.
Journal of Hematology & Oncology|January 7, 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registryClaire Lacan, Jérôme Lambert, Edouard Forcade, et al.
Pageof 18